Introduction
Transient suppression of cardiac function following prolonged strenuous endurance exercise (PSE) is well documented (Lord et al. 2014 ). There are frequent reports of a decrease in early passive transmitral left ventricular filling rate (E) that is compensated for by an increase in late diastolic left ventricular filling due to atrial contraction (A) following PSE (George et al. 2005; Oosthuyse et al. 2012; Shave et al. 2002 Shave et al. , 2004a Whyte et al. 2000; Williams et al. 2009 ). This culminates in a reduced left ventricular E:A ratio measured by pulsed-wave Doppler or tissue Doppler imaging; an earmark of suppressed left ventricular (LV) diastolic function. Early diastolic recoil during isovolumetric relaxation is impaired after PSE resulting in delayed and decreased untwisting of the LV and therefore decreased diastolic suction which explains the stunted early diastolic filling (Nottin et al. 2009 (Nottin et al. , 2012 . In more prolonged intense exercise or in less trained athletes the decrease in LV diastolic function can progress to decrease LV systolic function as noted by a decreased ejection fraction (EF) or measures of contractility (systolic blood pressure/end systolic volume, SBP/ESV) (Haykowsky et al. 2001; Oosthuyse et al. 2012; Shave et al. 2002 Shave et al. , 2004a Whyte et al. 2000; Williams et al. 2009 ), reductions in LV strain and strain rate (George et al. 2009; Scott et al. 2009 ) and degree of rotational LV twisting (Nottin et al. 2009 ) during systole. While recent evidence suggests that such suppression of cardiac function may originate from mechanical factors relating to an increase in pulmonary arterial pressure (Claessen et al. 2014; Lord et al. 2015; Trivax et al. 2010) , it may also arise from intrinsic metabolic disturbances within the myocytes (Vitiello et al. 2011 ) that occur during intense prolonged exercise. (Hart et al. 2006; Scott et al. 2007; Welsch et al. 2005) , although contended by others (Vitiello et al. 2011) , also suggests that prolonged elevations in sympathetic nervous system activity and systemic catecholamines during PSE may cause beta adrenergic desensitization and contribute to reduced systolic performance after PSE.
Carbohydrate supplements are ingested during endurance exercise in order to better maintain energy balance, delay endogenous carbohydrate depletion and maintain blood glucose concentration (Bosch et al. 1994) . As a result, carbohydrate supplements reduce the stress hormone, oxidative stress (McAnulty et al. 2007 ) and lipolytic (De Glisezinski et al. 1998) (Jeukendrup et al. 2011) , which may be more substantial and prevent the reduction in LV function as previously reported.
In addition, some studies (Saunders et al. 2004 (Saunders et al. , 2007 Skillen et al. 2008; Valentine et al. 2008) but not all (Breen et al. 2010; Van Essen and Gibala 2006) Most of these previous studies have used whey protein, which is a milk-derived protein and is a popular protein supplement in sports because whey protein is rapidly absorbed, includes all of the essential amino acids and has a high proportion of branched-chain amino acids (Calbet et al. 2004) . Moreover, some (Seifert et al. 2006) but not all (Hobson and James 2015) studies
show that carbohydrate-whey protein ingestion increases plasma osmolality and rehydration during recovery following exercise compared with carbohydrate-only ingestion. Whether such a response occurs when ingesting a carbohydrate-protein supplement during exercise is indeterminate, but if so, may be expected to better maintain plasma volume and hence preload during exercise. Lastly, the cysteine component of proteins possesses antioxidant activity by providing substrate for glutathione synthesis which may assist to reduce the oxidative stress imposed by PSE (Mariotti et al. 2004; Liu et al. 2014) . Whey protein contains the protein alpha-lactalbumin that has a particularly high content of cysteine (Mariotti et al. 2004) , and the small peptide fragments of a whey hydrolysate produce greater antioxidant capacity compared to when ingesting intact whey isolate (Liu et al. 2014 proportion of branched-chain amino acids when compared with whey (Calbet et al. 2004 ).
However, owing to the slow digestion time of intact casein, it is only suitable for ingestion during exercise as a casein hydrolysate where the absorption rate at rest has been shown to be matched to that of a whey hydrolysate (Calbet et al. 2004) . 
Materials and methods

Participants
Eight healthy, well-trained male cyclists aged 38.9 ± 6.3 years, with a body mass of 78.5 ± 7.1 kg, height of 179.8 ± 3.6 cm and percentage body fat of 17.4 ± 3.0% volunteered to take part in this study. The cyclists had 6.7 ± 1.7 years of competitive cycling experience, trained on average 11.1 ± 2.8 h·wk -1 , had a peak aerobic capacity (VO 2peak ) of 60. (Jeacocke and Burke 2010) . Training and dietary records were checked for compliance on the morning of each trial.
Experimental trials
The experimental trials were performed 7 days apart using a randomised, double-blind, fourway crossover design as previously described (Oosthuyse et al., 2015 C and 47 ± 14% relative humidity).
Experimental beverages
As detailed previously (Oosthuyse et al. 2015) , all beverages besides the placebo were prepared as a 7% carbohydrate solution and according to the drinking routine already described, provided 63 g of carbohydrate·h -1 and 900 mL·h -1
. tri-and di-peptides (<1000 Dalton) whereas the whey hydrolysate was composed of 70.8%
tri-and di-peptides (<1000 Daltons), 12.9% 1000-5000 Daltons peptides, 6.6% 5000-20000
Daltons peptides, and 9.5% >20000 Daltons peptides (Table 1 ). The experimental beverages (CHO-only, CHO-whey and CHO-casein) were therefore not isocaloric but rather isocarbohydrate in accordance with the recent reports for a carbohydrate dose response curve for carbohydrate ingestion during exercise and exercise performance (Smith et al. 2013) , which motivates against the use of a lower carbohydrate dose in the protein beverages as that may mask the true effect of the added protein. Furthermore, evidence suggests that the benefits of ingesting additional protein during exercise is related to alterations in key metabolic regulators (Kainulainen et al. 2013; Morato et al. 2013) Early (E) and atrial (A) peak blood flow velocities were recorded and the E/A ratio was calculated.
Tissue-Doppler imaging (TDI) of the septal (Sep) and lateral (Lat) wall at the level of the mitral annulus was performed to record peak early diastolic (e') and late diastolic (a') myocardial tissue velocities and e'/a' ratio was calculated. Peak systolic ejection velocity (s') was also recorded (Edvardsen et al. 2002) . The E/e' ratio was derived using an average of septal and lateral e' as an index of LV filling pressure. Cohen's effect size (ES) was calculated, where the standardised difference is ranked as follows: 0.0-0.2 is trivial; 0.2-0.6 is small; 0.6-1.2 is moderate; and 1.2-2.0 is a large effect.
Results
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Measures of fluid balance and cardiac loading Fluid retention, urine volume, urine osmolality and free water clearance were similar between all trials (Table 2) . However, the change in plasma osmolality from pre-exercise to 30 min post exercise tended to be different between treatments (F = 2.98, p = 0.06); Bonferroni post hoc test revealed the trend for a difference (p = 0.05) to occur between the placebo trial and the CHO-casein trial (Table 2 ). ***insert Table 2 near here*** Measures of preload, namely, EDV, LA/Ao and E/e' did not change from pre-to post exercise in any trial (Table 3) CHO-casein: -10(-18;-2) mmHg; CHO-whey: -12(-21;-3) mmHg) (Table 3) . Interestingly, post exercise SBP was significantly lower and more reduced from pre-exercise values during the placebo trial than the CHO-casein and tended to be lower than the CHO-whey trials (mean difference (95%CI) in post exercise SBP: placebo minus CHO-casein -9(-16;-1) mmHg, p = 0.02; placebo minus CHO-whey -7(-15;0.5) mmHg, p = 0.07). Furthermore, the decrease in diastolic blood pressure (DBP) from pre to post exercise was significant during the placebo, CHO-only and CHO-whey trials, but not significant during the CHO-casein trial (p = 0.27) ( Table 3 ). ***insert While no significant treatment-by-time interaction was evident, a time effect was significant for all measures of diastolic function where post hoc analysis reveals a significant time effect in only certain trials (Table 4) .
Pulsed-wave Doppler measures revealed a large effect size for a significant decrease in the early to late LV transmitral filling velocity ratio (E:A) from pre to post exercise in all trials;
where the rate of early filling (E) was reduced and the rate of late filling due to atrial contraction (A) increased (Table 4) .
Tissue Doppler imaging measures revealed a moderate to large effect size where the early to late diastolic ratio (e':a') of tissue velocity at the septal and lateral LV wall was significantly decreased from pre-to post exercise in the placebo, CHO-only and CHO-whey trials, but not in the CHO-casein trial (Table 4 ). ***insert Table 4 near here***
Systolic function
While no treatment-by-time interactions were significant, a significant time effect was evident in most measures of systolic function described by a small to moderate effect size (Table 5) ; albeit post hoc analysis identified significant time effects in only certain trials and indices. Ejection fraction was significantly suppressed from pre to post exercise in the placebo trial only. However, the SBP/ESV ratio as a measure of LV contractility was significantly suppressed in the placebo, CHO-only trials and tended to be suppressed in the CHO-whey trial but not in the CHO-casein trial. However, it is also interesting to note that the degree of significance and the effect size describing the change in SBP/ESV from pre to post exercise was larger in the placebo trial than the CHO-only and CHO-whey trials.
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Furthermore, the measure of ventricular-arterial coupling, SV/ESV, was only significantly reduced from pre to post exercise in the placebo trial. ***insert Giannaki et al. (2008) found that a recovery HR of 80 bpm, following short duration low intensity cycling, significantly elevated only pulsed-wave Doppler measures of peak LV filling velocity (A) but not TDI measures of peak LV myocardial velocity (a') during atrial contraction, compared to preexercise resting measurements (50 bpm), without any effect on both early filling (E) and tissue velocity (e'). Therefore in the current study, while the significantly suppressed early D r a f t filling (E) measured by pulsed-wave Doppler with all beverages may suggest an equally impaired diastolic function in all trials, the finding that the CHO-casein supplement alone was effective in mitigating the effect of PSE on TDI measures of diastolic function is especially noteworthy.
A reduced E:A (or e':a') is typically a consequence of decreased LV relaxation and hence reduced early filling that is compensated for by a more forceful left atrial contraction during late diastolic filling. With an unchanged preload, LV relaxation is thought to be impaired post PSE as a consequence of a metabolic energy deficit and reactive oxygen species that hamper calcium sequestering post contraction (Scott and Warburton 2008) . Whether the reduced negative effect on diastolic function noted with the CHO-casein supplement was owing to an effective reduction in the oxidative stress response to exercise or by some other mechanism leading to better maintenance of metabolic pathways, energy production and calcium sequestration, remains to be elucidated. Furthermore, whether the previously documented shift in substrate partitioning in favour of fat and away from carbohydrate oxidation when ingesting CHO-casein compared to CHO-only supplements during exercise (Oosthuyse et al. 2015) contributed in any way towards preserving cardiac function possibly through minimising the accumulated energy deficit is uncertain. Impeded LV relaxation may also occur following PSE secondary to the occurrence of RV dilatation (Claessen et al. 2014 ). RV dilatation is imposed by an increased pulmonary arterial pressure that coincides with strenuous exercise and displaces the inter-ventricular septum which impedes rapid LV untwisting during early diastole (Nottin et al. 2009; Lord et al. 2104) . In fact, the rapid untwisting or elastic recoil that occurs during isovolumetric relaxation at rest before exercise, which is partly due to energy stored within the extracellular connective tissue during systolic twisting, is responsible for the diastolic suction driving early filling (Nottin et al. 2009 ). This rapid untwisting is delayed or abolished post PSE and may also be a consequence of either a D r a f t 19 delay in LV peak torsion during systole as noted after an ironman triathlon (Nottin et al. 2009) or an increase in the end-systolic rotation as noted after 2 h of constant pace cycling (Nottin et al. 2012) . The CHO-casein supplement also tended to be the only supplement to better maintain systolic function post PSE, and thereby may have contributed towards the maintenance of diastolic function when ingesting this supplement, which requires validation by further studies assessing LV twisting and untwisting. to lessen the imbalance in redox status which drives NADPH oxidase activity. Furthermore, the cysteine amino acids provided in the whey and casein hydrolysates provide substrate for glutathione synthesis that may be expected to reduce the oxidative stress imposed by exercise (Mariotti et al. 2004) . Whey is richer in cysteine content than casein and ingested whey and casein hydrolysates are absorbed at similar rates at rest (Calbet et al. 2004 ). However, it is possible that during exercise, with reduced splanchnic blood flow, the longer chain peptides D r a f t 20 that constitute the whey may have been hydrolysed and absorbed slower than the purely diand tri-peptides constituting the casein hydrolysate, but this remains to be determined.
Nevertheless, it may support a possible mechanism explaining why the CHO-casein supplement tended to be more effective in maintaining both diastolic and systolic function following PSE in the current study. Moreover, it has previously been demonstrated that only selected short-chain peptides constituting a whey hydrolysate actively stimulated specific metabolic signalling pathways (Morato et al. 2013) . Therefore, future studies should investigate whether the various di-or tri-peptides making up the casein hydrolysate confer specific molecular signalling advantages to promote maintenance of cardiac function during exercise.
CHO-casein, followed by CHO-whey, appeared to be the only supplements to better maintain SBP/ESV, as a measure of LV contractility, following PSE. However, other measures of systolic function, namely EF and ventricular-arterial coupling (SV/ESV) were maintained with all three energy supplements (CHO-only, CHO-whey and CHO-casein), yet were compromised only with placebo ingestion. Previously, CHO supplement ingestion (0.9 g/kg/h) during 2.5 h of cycling (60% Wmax) reduced the stress hormone response and oxidative stress in athletes who participated 4.5 h postprandially compared to placebo ingestion (McAnulty et al. 2007) . Therefore, although tending to be less effective than the CHO-casein supplement, the CHO-only and CHO-whey supplement may have nevertheless reduced the stress hormone response, oxidative stress and energy deficit that would be expected to occur with placebo ingestion. This may possibly explain the more notable negative effect of PSE on systolic function observed during the placebo trial than during the energy supplemented trials.
The typical decrease in SBP post exercise is related to an expected decrease in vascular resistance during exercise (Nottin et al. 2012) . By Frank-Starling relation a reduced afterload
should result in an increase in stroke volume that should reduce ESV and cause the SBP/ESV relation to be unchanged. Thus, the decrease in SBP/ESV noted in the placebo, CHO-only and tended to occur in the CHO-whey trials but not in the CHO-casein trial in the current study would imply a decrease in contractility and systolic performance in those former trials.
It is interesting that SBP was reduced by a smaller amount in the CHO-protein trials, and especially the CHO-casein trial, compared with the placebo trial. The ingestion of added protein can be expected to increase plasma osmolality (Seifert et al. 2006 ) mainly due to an increase in plasma albumin content which is compensated for by an increase in plasma volume (Hobson and James 2015) . In the current study, plasma osmolality appeared to increase from pre-exercise to 30 min post exercise in the CHO-casein trial and decrease in the placebo trial, which resulted in the change in plasma osmolality to tend to be different between these two trials. Although not measured, it may be that the tendency for an increase in osmolality in the CHO-casein trial was due to an increase in plasma albumin content, The greater HR post exercise compared to pre-exercise in all trials is typically reported in all previous studies evaluating the influence of PSE on cardiac function (George et al. 2009; Shave et al. 2004a; Whyte et al. 2000) and cannot solely account for the decrements noted to cardiac function as evidence of cardiac suppression is even more notable when evaluated during exercise at equivalent HR before and after PSE (Claessen et al. 2014 ).
The acquisition of left ventricular dimensions from 2D echocardiography for the calculation of left ventricular volume is acceptable by American Society of Echocardiographic (ASE) standards (Sahn et al. 1978; Schiller et al. 1989 ) and has been widely applied in exercise science (Shave et al. 2002 (Shave et al. , 2004a (Shave et al. , 2004b Whyte et al. 2000 Whyte et al. , 2005 . However, updated ASE standards prefer the use of Simpson's biplane method for the estimation of LV volumes (Lang et al. 2005) . Calculation of LV volume based on dimensions assumes that the LV is elliptical in shape and while this is largely acceptable for healthy individuals, LV shape may be altered by cardiac injury such as myocardial infarction and in such cases invalidates the underlying assumption. However, in the current study all participants were healthy and presented no history of cardiac disease. Furthermore, all comparisons were within participant repeated measures design where the main effect of interest was the change over time in a given measured variable with less emphasis on the absolute values.
Lastly, the sample size of the study was small and the observed beverage-specific significant pre-to-post exercise time-effects without significant treatment-by-time interactions motivates for verification with a larger sample size. D r a f t 
Conclusion
